Artia Global Partners LP has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $517 Billion distributed in 46 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Novo Nordisk A S with a value of $98.7B, Eli Lilly & CO with a value of $83.8B, Merck & Co., Inc. with a value of $54.8B, Viking Therapeutics, Inc. with a value of $24B, and Astrazeneca PLC with a value of $14.9B.

Examining the 13F form we can see an increase of $19.8B in the current position value, from $498B to 517B.

Artia Global Partners LP is based out at Miami, FL

Below you can find more details about Artia Global Partners LP portfolio as well as his latest detailed transactions.

Portfolio value $517 Billion
Healthcare: $381 Billion

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 46
  • Current Value $517 Billion
  • Prior Value $498 Billion
  • Filing
  • Period Q2 2024
  • Filing Date August 14, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 7 stocks
  • Additional Purchases 8 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Artia Global Partners LP Portfolio

Follow Artia Global Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artia Global Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Artia Global Partners LP with notifications on news.